Overview
Lobbying Costs
150,000€
Financial year: Apr 2015 - Mar 2016
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
Takeda Pharmaceuticals International GmbH (TPI Zurich)
EU Transparency Register
815176718826-78 First registered on 17 Sep 2015
Goals / Remit
Takeda is a global pharmaceutical company that focuses on innovative medicines in gastroenterology, oncology, central nervous system, cardiovascular and metabolic, as well as vaccines. The portfolio of quality, established prescription and over-the-counter medicines helps patients around the world. Takeda’s mature markets – Japan, United States and Europe – remain strong cornerstones of our business as we continue to grow our presence in emerging markets, such as Brazil, Russia and China. In Europe the company has a presence that covers 30 countries and commercial headquarters in Zurich, Switzerland. To learn more please visit us at www.takeda.com
Main EU files targeted
We follow EU initiatives, policies and legislative files related to our Pharmaceuticals and Vaccines businesses. This includes topics such as R&D and clinical trials, data protection, relevant legislation and initiatives, medical devices, trade & IP, environment.
Address
Head Office
Thurgauerstrasse 130
Glattpark-Opfikon
Zurich 8152
SWITZERLANDEU Office
Gentsesteenweg 615
Brussels
BELGIUM -
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 22 Sep 2016
Name Start date End Date Toon DIGNEFFE 05 Oct 2019 03 Oct 2020 Mr Richard CORLISS 05 Oct 2019 03 Oct 2020 Complementary Information
Staff who only occasionally contribute to activities covered by the register, or who do not perform significant activities other than normal participation by organisation representatives in EFPIA, Vaccines Europe and similar working groups, are excluded from the above calculation.
Person in charge of EU relations
Ms Styliadou Meni (Head of External Affairs, Europe/Canada)
Person with legal responsibility
Mr Princen Marc (President EUCAN Business Unit)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Takeda is a member of European Federation of Pharmaceutical Industries and Associations (EFPIA) and Vaccines Europe (VE)
Member organisations
None declared
-
Financial Data
Closed financial year
Apr 2015 - Mar 2016
Lobbying costs for closed financial year
150,000€
Other financial info
In the interest of simplicity and reduction of administrative burden of compiling the estimate, the cost of normal participation by organisation representatives in EFPIA, Vaccines Europe and similar working groups has been excluded, unless such representatives perform a significant amount of work on other relevant activities covered by the Register
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
Mainly via participation at events organised by Trade Associations (e.g. EFPIA).
Other activities
Staff who only occasionally contribute to activities covered by the register, or who do not perform significant activities other than normal participation by organisation representatives in EFPIA, Vaccines Europe and similar working groups, are excluded from the above calculation.
Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 20 Jan 2023 Location Brussels Subject EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Elina Melngaile (Cabinet member)
Other Lobbyists -
Date 14 Sep 2017 Location Brussels, Belgium Subject eHealth Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Manuel Mateo-Goyet (Cabinet member)